This article is part of the supplement: Optimizing the use of carbapenems in the face of increasing Gram-negative resistance
Gram-negative antibiotic resistance: there is a price to pay
-
Correspondence: Thomas G Slama slamaidi@aol.com
Critical Care 2008, 12(Suppl 4):S4 doi:10.1186/cc6820
Accesses
- Last 30 days: 183 accesses
- Last year: 2572 accesses
- All time: 13424 accesses
Cited by
BioMed Central: 2 citations
|
Ji-Guang Ding, Qing-Feng Sun, Ke-Cheng Li, Ming-Hua Zheng, Xiao-Hui Miao, Wu Ni, Liang Hong, Jin-Xian Yang, Zhan-Wei Ruan, Rui-Wei Zhou, Hai-Jiao Zhou, Wen-Fei He BMC Infectious Diseases 2009, 9:115 (25 July 2009) |
|
Optimizing the use of carbapenems in the face of increasing Gram-negative resistance Reuben Ramphal Critical Care 2008, 12(Suppl 4):S1 (21 May 2008) |